AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call Transcript
Pascal, please go ahead.
Thank you. Welcome, everyone, and thank you very much for joining us for today's webinar. My name is Pascal Soriot. I'm the CEO of AstraZeneca. I apologize we are taking you away from your weekend. But as you can imagine, this is a very material transaction for our company and for Alexion. And as soon as the Boards of both companies agreed on this merger of the 2 companies, we, of course, had to announce it. And also, I guess the benefit of announcing today is that it gives investors and analysts a weekend to think about this transaction and the consequences and the implications and the importance of it.
I'm joined today by Marc Dunoyer, the CFO of AstraZeneca; as well as Mene Pangalos, who is our EVP of Biopharmaceuticals R&D. On the Alexion side: Ludwig Hantson, the CEO of Alexion, is with us; as well as Aradhana Sarin, who is the CFO of Alexion. We also have members of the AstraZeneca IR team and members of the Alexion team
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
